We began by assessing NFκB activation by Western blot analysis of nuclear extracts; we found decreased nuclear localization of the NFκB subunits p65 and p50 in non-tumor bearing epidermis and tumors but no change in p52 (Figure 5C). This evidence concerns the gene NFKB1 and neoplasm.